Dufès C - Search Results

1

Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown.

Obeid MA, Dufès C, Somani S, Mullen AB, Tate RJ, Ferro VA. Obeid MA, et al. Among authors: dufes c. J Liposome Res. 2019 Sep;29(3):229-238. doi: 10.1080/08982104.2018.1531424. Epub 2019 Jan 1. J Liposome Res. 2019. PMID: 30296860

2

Liposomes encapsulating polymeric chitosan based vesicles--a vesicle in vesicle system for drug delivery.

McPhail D, Tetley L, Dufes C, Uchegbu IF. McPhail D, et al. Among authors: dufes c. Int J Pharm. 2000 Apr 25;200(1):73-86. doi: 10.1016/s0378-5173(00)00348-3. Int J Pharm. 2000. PMID: 10845688

3

Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting.

Dufes C, Schätzlein AG, Tetley L, Gray AI, Watson DG, Olivier JC, Couet W, Uchegbu IF. Dufes C, et al. Pharm Res. 2000 Oct;17(10):1250-8. doi: 10.1023/a:1026422915326. Pharm Res. 2000. PMID: 11145231

4

Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles.

Fu JY, Blatchford DR, Tetley L, Dufès C. Fu JY, et al. Among authors: dufes c. J Control Release. 2009 Dec 3;140(2):95-9. doi: 10.1016/j.jconrel.2009.08.017. Epub 2009 Aug 23. J Control Release. 2009. PMID: 19709637

5

Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA.

Koppu S, Oh YJ, Edrada-Ebel R, Blatchford DR, Tetley L, Tate RJ, Dufès C. Koppu S, et al. Among authors: dufes c. J Control Release. 2010 Apr 19;143(2):215-21. doi: 10.1016/j.jconrel.2009.11.015. Epub 2009 Nov 26. J Control Release. 2010. PMID: 19944722

6

Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex.

Aldawsari H, Raj BS, Edrada-Ebel R, Blatchford DR, Tate RJ, Tetley L, Dufès C. Aldawsari H, et al. Among authors: dufes c. Nanomedicine. 2011 Oct;7(5):615-23. doi: 10.1016/j.nano.2011.01.016. Epub 2011 Feb 17. Nanomedicine. 2011. PMID: 21333755

7

Novel tocotrienol-entrapping vesicles can eradicate solid tumors after intravenous administration.

Fu JY, Zhang W, Blatchford DR, Tetley L, McConnell G, Dufès C. Fu JY, et al. Among authors: dufes c. J Control Release. 2011 Aug 25;154(1):20-6. doi: 10.1016/j.jconrel.2011.04.015. Epub 2011 Apr 22. J Control Release. 2011. PMID: 21539872

8

Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex.

Aldawsari H, Edrada-Ebel R, Blatchford DR, Tate RJ, Tetley L, Dufès C. Aldawsari H, et al. Among authors: dufes c. Biomaterials. 2011 Sep;32(25):5889-99. doi: 10.1016/j.biomaterials.2011.04.079. Epub 2011 May 18. Biomaterials. 2011. PMID: 21596431

9

Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system.

Lemarié F, Croft DR, Tate RJ, Ryan KM, Dufès C. Lemarié F, et al. Among authors: dufes c. Biomaterials. 2012 Mar;33(9):2701-9. doi: 10.1016/j.biomaterials.2011.12.019. Epub 2011 Dec 24. Biomaterials. 2012. PMID: 22200536

10

Delivery of the vitamin E compound tocotrienol to cancer cells.

Dufès C. Dufès C. Ther Deliv. 2011 Nov;2(11):1385-9. doi: 10.4155/tde.11.120. Ther Deliv. 2011. PMID: 22826870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results